5-HT3 antagonist ICS 205-930 enhances naltrexone's effects on ethanol intake

European Journal of Pharmacology

Volumn 491, Issue 2-3, 2004, Pages 149-156

  Mhatre, Molina ^a,b   Pruthi, Ravindar ^a   Hensley, Kenneth ^a   Holloway, Frank ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

5 HT3 receptor; Alcoholism; Naltrexone; Opioid receptor

Indexed keywords

ALCOHOL; NALTREXONE; SEROTONIN 3 ANTAGONIST; TROPISETRON; INDOLE DERIVATIVE; SEROTONIN 3 RECEPTOR; SEROTONIN ANTAGONIST;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG ANTAGONISM; DRUG POTENTIATION; SPRAGUE DAWLEY RAT;

ALCOHOL DRINKING; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ETHANOL; INDOLES; MALE; NALTREXONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS;

EID: 2342620678     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.03.011     Document Type: Article

References (37)

1. Ait-Daoud N.A., Johnson B.A., Prihoda T.J., Hargita I.D. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence. Psychopharmacology (Berl.). 154:2001;23-27
2. Anton R.F., Moak D., Waid L., Latham P.K., Malcolm R.J., Dias J.K. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am. J. Psychiatry. 156:1999;1758-1764
3. 4 binding site in human brain. J. Neural. Transm. 105:1998;575-586
4. Buchheit K.H., Costall B., Engel G., Gunning S.J., Naylor R.J., Richardson B.P. 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205-930 in the guinea pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in vivo. J. Pharm. Pharmacol. 37:1985;664-667
5. Campbell A.D., McBride W.J. Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens. Pharmacol. Biochem. Behav. 51:1995;835-842
6. 3 antagonists on drug induced stimulation of dopamine release. Eur. J. Pharmacol. 164:1989;515-519
7. Cooper S.J., Jackson A., Kirkham T.C. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia. Pharmacol. Biochem. Behav. 23:1985;889-901
8. Corbett A.D, Paterson S.J., Kosterlitz H.W. Selectivity of ligands for opioid receptors. Herz A. Handbook of Pharmacology: Opioids. 1993;645-679 Springer-Verlag, New York, NY
9. 4 receptor. Int. Clin. Psychopharmacol. 8:1993;11-18
10. De Zwaan M., Mitchell J.E. Opiate antagonists and eating behavior in humans: a review. J. Clin. Pharmacol. 32:1992;1060-1072
11. 3 antagonist, suppresses voluntary ethanol consumption in alcohol preferring rats. Alcohol Alcohol. 26:1991;107-110
12. Files F.J., Samson H.H., Brice G.T. Sucrose, ethanol, and sucrose/ethanol reinforced responding under variable-interval schedules of reinforcement. Alcohol., Clin. Exp. Res. 19:1995;1271-1278
13. 3 receptor antagonists. Psychopharmacology (Berl.). 104:1991;451-456
14. 3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning. Psychopharmacology (Berl.). 106:1992;315-320
15. 3 antagonist ICS 205-930. Alcohol. 10:1993;191-196
16. 3/4 antagonist tropisetron. Psychopharmacology. 119:1995;186-192
17. Huang C.T., Chen C.F., Tsai T.H. Measurement and pharmacokinetic study of unbound tropisetron in rat blood by microdialysis with high-performance liquid chromatography. Int. J. Pharm. 182:1999;237-242
18. 3 receptor antagonists, which prevent the effects of ethanol on extracellular dopamine, and fail to reduce voluntary alcohol intake in rats. Farmaco. 52:1997;141-146
19. Johnson B.A., Ait-Daoud N., Prihoda T.J. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence. Alcohol., Clin. Exp. Res. 24:2000;737-742
20. 3-receptor antagonist, reduces voluntary ethanol consumption in rats. Pharmacol. Biochem. Behav. 41:1992;847-850
21. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184
22. 3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats. Alcohol. 10:1993;369-373
23. Litten R.Z., Allen J.P. Advances in development of medications for alcoholism treatment. Psychopharmacology. 139:1998;20-33
24. Lovinger D.M., White G. Ethanol potentiation of 5-hydroxytryptamine-3 receptor-mediated ion current in neuroblastoma cells and isolated neurons. Mol. Pharmacol. 40:1991;263-270
25. McKinzie D.L., Eha R., Cox R., Stewart R.B., Dyr W., Murphy J.M., McBride W.J., Lumeng L., Li T.-K. Serotonin-3 receptor antagonism of alcohol intake: effects of drinking conditions. Alcohol. 15:1998;291-298
26. Mhatre M.C., Holloway F.A. μ1-Opiate antagonist, naloxonazine alters ethanol's discriminative effects and ethanol drinking behavior. Alcohol. 23:2003;168-172
27. 3-receptor antagonist ICS 205-930 alters the discriminative effects of ethanol. Pharmacol. Biochem. Behav. 68:2001;163-170
28. Middlemiss D.N., Tricklebank M.D. Centrally active 5-HT receptor agonists, antagonists. Neurosci. Biobehav. Rev. 16:1992;75-82
29. Naranjo C.A., Kadlec K., Sanhueza P., Woodley-Remus D.V., Sellers E.M. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin. Pharmacol. Ther. 47:1990;490-498
30. O'Malley S., Jaffe A., Chang G., Schottenfield R., Meyer R., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch. Gen. Psychiatry. 49:1992;881-887
31. 4 receptor antagonist GR 113808, reduces ethanol intake in alcohol-preferring rats. Pharmacol. Biochem. Behav. 52:1995;255-259
32. 3 receptor antagonists: differences and similarities. Eur. J. Cancer. 33:1997;1364-1370
33. 3 antagonist ondansetron in alcohol abuse and dependence. Alcohol., Clin. Exp. Res. 18:1994;879-885
34. Simpson K., Spencer C.M., McClellan K.J. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs. 59:2000;1297-1315
35. Swift R.M., Davidson D., Whelihan W., Kuznetsov O. Ondansetron alters human alcohol intoxication. Biol. Psychiatry. 40:1996;514-521
36. 3-antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure. Psychopharmacology. 117:1995;479-485
37. Volpicelli J., Alterman A., Hayashida M., O'Brien C. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry. 49:1992;876-880